Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Marc Smaldone

Email
Center AffiliationsCancer Prevention and Control

Publications (147) (print view)

no pagination
Ristau BT, Kutikov A, Uzzo RG, Smaldone MC. Active Surveillance for Small Renal Masses: When Less is More. European urology focus. 2016 Dec 15;2(6):660-8.
Ristau BT, Smaldone MC. Radical prostatectomy in metastatic prostate cancer: is there enough evidence? vertical bar Opinion: No. International Braz J Urol. 2016 Sep;42(5):880-2.
Ristau BT, Smaldone MC. Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No. International braz j urol : official journal of the Brazilian Society of Urology. 2016 Sep;42(5):880-2.   PMCID: PMC5066883
Ristau BT, Smaldone MC. Radical prostatectomy in metastatic prostate cancer: is there enough evidence? vertical bar Opinion: No. International Braz J Urol. 2016 Sep;42(5):880-2.
Shaikh T, Ruth K, Devarajan K, Zaorsky NG, Hallman MA, Sobczak ML, Chen D, Uzzo R, Smaldone MC, Kutikov A, Greenberg RE, Viterbo R, Pollack A, Horwitz EM. Dosimetric and Clinical Predictors of Long-Term Toxicity in Patients Undergoing Hypofractionated Prostate Radiation Therapy: Results From a Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2):S123.
Wang EH, Abouassaly R, Yu JB, Meropol NJ, Cooper G, Shah N, Williams SB, Gonzalez C, Smaldone MC, Kutikov A, Zhu H, Kim SP. Disparities in Access and Treatment of Patients With High-Risk Prostate Cancer: Results From a Population-Based Cohort. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):E258.
Wang EH, Yu JB, Abouassally R, Meropol NJ, Cooper G, Shah ND, Williams SB, Gonzalez C, Smaldone MC, Kutikov A, Zhu H, Kim SP. Disparities in Treatment of Patients with High-Risk Prostate Cancer: Results From A Population-Based Cohort. Urology. 2016 Jun 15;95:88-94.
Wang EH, Yu JB, Abouassally R, Meropol NJ, Cooper G, Shah ND, Williams SB, Gonzalez C, Smaldone MC, Kutikov A, Zhu H, Kim SP. Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort. Urology. 2016 Sep;95:88-94.
Zaorsky NG, Churilla TM, Ruth K, Hayes SB, Sobczak ML, Hallman MA, Smaldone MC, Chen DY, Horwitz EM. Men's health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer. The American journal of clinical nutrition. 2016 Dec;104(6):1583-93.   PMCID: PMC5118729
Zaorsky NG, Handorf E, Horwitz EM, Hallman MA, Smaldone MC. Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 2016 Oct;96(2):E280.
Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D. Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw. 2015 Dec;13(12):1534-61.
Corcoran AT, Kaffenberger SD, Clark PE, Walton J, Handorf E, Piotrowski Z, Tomaszewski JJ, Ginzburg S, Mehrazin R, Plimack E, Chen DY, Smaldone MC, Uzzo RG, Morgan TM, Kutikov A. Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy. BJU international. 2015 Sep;116(3):351-7.
Corcoran AT, Handorf E, Canter D, Tomaszewski JJ, Bekelman JE, Kim SP, Uzzo RG, Kutikov A, Smaldone MC. Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type. BJU international. 2015 Feb;115(2):230-7.
Ginzburg S, Uzzo R, Walton J, Miller C, Kurz D, Li T, Handorf E, Gor R, Corcoran A, Viterbo R, Chen DY, Greenberg RE, Smaldone MC, Kutikov A. Residual Parenchymal Volume, Not Warm Ischemia Time, Predicts Ultimate Renal Functional Outcomes in Patients Undergoing Partial Nephrectomy. Urology. 2015 Jul 18;86(2):300-6.
Haseebuddin M, Smaldone MC. Treatment of localized prostate cancer in elderly patients. Gland Surg. 2015 Aug;4(4):283-7.   PMCID: PMC4523629
Ito T, Abbosh PH, Mehrazin R, Tomaszewski JJ, Li T, Ginzburg S, Canter DJ, Greenberg RE, Viterbo R, Chen DY, Kutikov A, Smaldone MC, Uzzo RG. Surgical apgar score predicts an increased risk of major complications and death after renal mass excision. Journal of Urology. 2015 Jan;193(6):1918-22.
Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N, Bekelman JE. Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer. JAMA Oncol. 2015 Jul 16;1(7):897-906.
Kiechle JE, Abouassaly R, Smaldone MC, Shah ND, Dong S, Cherullo EE, Nakamoto D, Zhu H, Cooney MM, Kim SP. National Trends of Local Ablative Therapy among Young Patients with Small Renal Masses in the United States. Urology. 2015 Sep;86(5):962-7.
Kim SP, Gross CP, Smaldone MC, Han LC, Van Houten H, Lotan Y, Svatek RS, Thompson RH, Karnes RJ, Trinh QD, Kutikov A, Shah ND. Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population. Prostate Cancer Prostatic Dis. 2015 Mar;18(1):13-7.
Kutikov A, Smaldone MC, Uzzo RG. Focal therapy for treatment of the small renal mass: Dealer's choice or a therapeutic gamble? [Comment; Editorial]. European Urology. 2015 Jan;67(2):260-1.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Marc Smaldone Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Wednesday, September 06, 2017